Very useful PEGACSSA74V1 real questions at killexams.com

Fed up with reading bulky Certified Senior System Architect (CSSA) 74V1 publications? Keep in thought, you will nevertheless see strange queries in real PEGACSSA74V1 which you never see within course books. The particular answer is in order to download PEGACSSA74V1 test prep from killexams.com and remember all the queries and answers. Exercise with VCE sim and then you are ready for genuine PEGACSSA74V1 exam.

Exam Code: PEGACSSA74V1 Practice test 2022 by Killexams.com team
Certified Senior System Architect (CSSA) 74V1
Pegasystems Certified basics
Killexams : Pegasystems Certified basics - BingNews https://killexams.com/pass4sure/exam-detail/PEGACSSA74V1 Search results Killexams : Pegasystems Certified basics - BingNews https://killexams.com/pass4sure/exam-detail/PEGACSSA74V1 https://killexams.com/exam_list/Pegasystems Killexams : Best Online Excel Classes Investopedia requires writers to use primary sources to support their work. These include white papers, government data, original reporting, and interviews with industry experts. We also reference original research from other reputable publishers where appropriate. You can learn more about the standards we follow in producing accurate, unbiased content in our editorial policy. Thu, 06 Oct 2022 12:00:00 -0500 en text/html https://www.investopedia.com/best-online-excel-classes-4845516 Killexams : Best Investing Courses

Final Verdict

If you’re looking to learn more about investing, there are plenty of great course options to choose from. Whether you’re invested in diving into the world of day trading or just want to understand how to save for retirement, these courses are great entry points. We recommend Udemy’s Stock Market From Scratch for Complete Beginners as the best overall course for its affordability and approachability.

Stock Market From Scratch for Complete Beginners features asynchronous learning that can fit with any schedule, as well as lifetime access to course materials. At $109.99, the course is one of the more affordable options on this list, and provides comprehensive coverage of investing basics for beginners and intermediate investors alike.

Compare the Best Investing Courses

Frequently Asked Questions

How Can I Learn to Invest?

Anyone can learn how to be a savvy investor, especially if they are armed with the right tools and resources.

If you want to teach yourself the tips and strategies necessary to make smart investments, think first about how you learn. Do you prefer a hands-on, DIY approach or do you retain information better when someone is personally guiding you through the steps? 

Next, research the best options to suit your schedule, budget, and learning style. This might mean taking an investing course at your local community college or signing up for a webinar. You could better benefit from an online investment simulator course or perhaps by browsing the educational libraries offered by many of the big brokerages.

Can I Start Investing With Little Money?

These days, anyone can get started investing, no matter the budget. You just need to know what types of investments are available to you based on the funds you are willing and able to invest.

You'll find a number of brokerage accounts out there with considerable minimum investment requirements; you may need to cough up $10,000 to open a web trading account with one broker, while another has a hefty $30,000 requirement, for instance. But luckily, there are just as many others that have low or no minimum requirements when it comes to opening an account and investing your funds.

Quite a few of today’s online brokerages allow for fractional investing, too, making it easier to invest in a small piece of the names you know and love, sometimes for as little as $1. And if you really want to simplify your investing efforts without feeling a big pinch, you can choose a platform that rounds up your everyday purchases and invests that spare change for you.

What Types of Investing Courses Are There?

No matter what type of investor you are or your experience level, there is an investing course for you. 

Some courses cover the basics of investing including stocks, bonds, mutual funds, and retirement funds. Others delve a bit deeper into futures and commodities, or even international investing. 

Of course, you can (and should) choose the course that best matches both your interests and your existing knowledge. If you are just getting your feet wet, there are basic investing courses designed to teach you about the market, how it works, and what the different types of investments can do for you and your portfolio. 

If you’ve been dabbling for years and either want to invest in something new or take your efforts up a notch, there are plenty of advanced courses to suit. 

How Much Do Investing Courses Cost?

Learning about investing doesn’t have to cost a fortune. In fact, many brokerages offer free online libraries to customers, allowing you to teach yourself a range of subjects at no cost at all. If the self-taught and self-paced approach is your style, this is a good way to save money—which you can put into your portfolio!

You can sign up for interactive courses—which include quizzes—for as low as $49. If you want to spend a bit more and get ongoing instruction, some courses offer plans for $99 a month, which can include online communities, live chats, and even 1-on-1 instruction. 

And of course, if you’re really looking to dive into your investing education and have the cash to spare, there are courses that easily run $4,000+ for 90 days of instruction.

Methodology

To choose the best investing courses available today, we looked at a number of trusted platforms and compared them against a range of educational criteria. We looked at the types of courses offered and the levels of education provided. We also looked at whether the classes involved any sort of live instruction, community involvement, or if they were self-paced or self-led.

To determine the best value, we also considered the price and what sort of course options were available for users, especially in terms of continued access and resources.

Thu, 10 Mar 2022 04:57:00 -0600 en text/html https://www.investopedia.com/best-investing-courses-4783334
Killexams : A Complete List of Diabetes Medications

Recall of extended-release metformin

In May 2020, the Food and Drug Administration (FDA) recommended that some makers of extended-release metformin remove some of their tablets from the U.S. market. This is because an unacceptable level of a probable carcinogen (cancer-causing agent) was found in some extended-release metformin tablets. If you currently take this drug, call a healthcare professional. They will advise whether you should continue to take your medication or if you need a new prescription.

Diabetes is a condition that leads to high levels of blood glucose (sugar) in the body.

This reaction happens when your body can’t make or use the hormone insulin like it’s supposed to. Produced by the pancreas, insulin helps your body use the sugar from the food you eat.

There are two major types of diabetes: type 1 diabetes and type 2 diabetes. People with either type need medications to help manage their blood sugar levels.

The types of medications you take will depend on the type of diabetes you have. Learn more about the available treatment options.

If you have type 1 diabetes, your body can’t make its own insulin. The goal of treatment is to replace the insulin that your pancreas can’t make.

Insulin

Insulin is the most common type of medication used in type 1 diabetes treatment. There are more than 20 types sold in the United States.

It’s given as an infusion under the skin (with the help of an insulin pump) or as an injection.

There are multiple types of insulin. They vary based on how quickly they start working, how long they work, and whether they have a peak level of action.

The type of insulin you need depends on your body’s sensitivity to insulin and the severity of your insulin deficiency. These include the following:

Short-acting insulin:

Regular or “short-acting” insulin may reach the bloodstream 30 minutes after injection and peak 2-3 hours afterward. These injections also work up to 3-6 hours.

Types of regular insulin include:

  • Humulin R U-100
  • Novolin R FlexPen
  • Novolin R ReliOn
  • Novolin R FlexPen ReliOn

Rapid-acting insulin:

As the name suggests, rapid-acting insulin works within 15 minutes. The peak time is 1 to 2 hours after use, and the medication lasts between 2 and 4 hours.

The available types of rapid-acting insulin include:

  • inhaled insulin (Afrezza)
  • insulin aspart (Fiasp, Fiasp FlexTouch, Fiasp PenFill, NovoLog, NovoLog FlexPen, NovoLog FlexTouch, NovoLog PenFill, ReliOn NovoLog, ReliOn NovoLog FlexPen)
  • insulin glulisine (Apidra, Apidra SoloStar), which is only available as a brand-name drug
  • insulin lispro (Admelog, Admelog SoloStar, Humalog, Humalog KwikPen, Humalog Junior KwikPen)
  • insulin lispro-aabc (Lyumjev, Lyumjev KwikPen)

Intermediate-acting insulin:

Intermediate-acting insulin works about 2-4 hours after use, with an average peak time of 12 hours. You can expect this type of insulin to last between 12 and 18 hours.

Examples include:

  • insulin isophane (Humulin N U-100, Humulin N KwikPen, Novolin N, Novolin N FlexPen, Novolin N ReliOn, Novolin N FlexPen ReliOn)

Long-acting insulin:

Long-lasting insulin helps lower your blood glucose levels for up to 24 hours or longer, and it reaches your bloodstream more gradually.

The types of available long-acting insulin include:

  • insulin degludec (Tresiba, Tresiba FlexTouch)
  • insulin detemir (Levemir)
  • insulin glargine (Basaglar KwikPen, Lantus, Lantus SoloStar, Toujeo SoloStar, Toujeo Max SoloStar)
  • insulin glargine-yfgn (Semglee-yfgn)
  • concentrated regular insulin (Humulin R U-500, Humulin R U-500 KwikPen)

Combination (premixed) insulins:

  • insulin aspart protamine/insulin aspart 70/30 (NovoLog Mix 70/30, NovoLog Mix 70/30 FlexPen)
  • insulin isophane/regular insulin 70/30 (Humulin 70/30, Humulin 70/30 KwikPen, Novolin 70/30, Novolin 70/30 FlexPen, Novolin 70/30 FlexPen ReliOn)
  • insulin lispro protamine/insulin lispro 50/50 (Humalog Mix 50/50, Humalog Mix 50/50 KwikPen)
  • insulin lispro protamine/insulin lispro 75/25 (Humalog Mix 75/25, Humalog Mix 75/25 KwikPen)

Amylinomimetic injectables

Pramlintide (SymlinPen) is an amylinomimetic. It’s an injectable medication that’s used before meals.

It works by delaying the time your stomach takes to empty itself. It also reduces the secretion of the hormone glucagon after meals. These actions lower your blood sugar.

Pramlintide reduces appetite, too.

If you have type 2 diabetes, your body makes insulin but no longer uses it well. Your body can’t make enough insulin to keep your blood sugar levels within an optimal range.

The goal of your treatment is to help your body use insulin better or to get rid of extra glucose in your blood.

Most medications for type 2 diabetes are oral drugs. However, insulin or injectables may also be used. Some of these medications are combinations of more than one diabetes drug.

Insulin

Some people with type 2 diabetes may also need to take insulin. The same types of insulin used to treat type 1 diabetes can also treat type 2 diabetes.

A doctor may recommend the aforementioned types of insulin used in type 1 diabetes treatment for type 2 diabetes. As with type 1 diabetes, this depends on the type of insulin needed and how severe your insulin deficiency is. See the above types of insulin to discuss with a doctor.

Alpha-glucosidase inhibitors

These medications help your body break down starchy foods and table sugar. This effect lowers your blood sugar levels.

When taken as prescribed, these medications won’t cause hypoglycemia (low blood sugar). However, your risk of hypoglycemia may be greater if you take them with other types of diabetes medications.

For best results, take alpha-glucosidase inhibitors before meals. These medications include:

Biguanides

Biguanides decrease how much glucose your liver makes. They also decrease how much glucose your intestines absorb, help your muscles absorb glucose, and make your body more sensitive to insulin.

The most common biguanide is metformin (Glumetza, Riomet, Riomet ER).

Metformin is considered the most commonly prescribed oral medication for type 2 diabetes, and it can also be combined with other type 2 diabetes medications. It’s an ingredient in the following medications:

  • metformin-alogliptin (Kazano)
  • metformin-canagliflozin (Invokamet)
  • metformin-dapagliflozin (Xigduo XR)
  • metformin-empagliflozin (Synjardy)
  • metmorfin-ertugliflozin (Segluromet)
  • metformin-glipizide
  • metformin-glyburide (Glucovance)
  • metformin-linagliptin (Jentadueto, Jentadueto XR)
  • metformin-pioglitazone (Actoplus Met, Actoplus Met XR)
  • metformin-repaglinide (PrandiMet)
  • metformin-rosiglitazone (Avandamet)
  • metformin-saxagliptin (Kombiglyze XR)
  • metformin-sitagliptin (Janumet, Janumet XR)

Dopamine-2 agonist

Bromocriptine (Cycloset, Parlodel) is a dopamine-2 agonist.

It’s unknown exactly how this drug treats type 2 diabetes. It may affect rhythms in your body and prevent insulin resistance. According to one 2015 review, dopamine-2 agonists may also Improve other related health concerns, such as high cholesterol or weight management.

Dipeptidyl peptidase-4 (DPP-4) inhibitors

DPP-4 inhibitors are used to help reduce blood sugar without causing hypoglycemia.

DPP-4 inhibitors block the DPP-4 enzyme. This enzyme destroys a hormone called incretin, which normally helps your body produce insulin when it’s needed. Incretins also decrease glucose output from the liver when your body doesn’t need it.

These drugs can also help the pancreas make more insulin.

Examples of DPP-4 inhibitors include:

  • alogliptin (Nesina)
  • alogliptin-metformin (Kazano)
  • linagliptin (Tradjenta)
  • linagliptin-empagliflozin (Glyxambi)
  • linagliptin-metformin (Jentadueto, Jentadueto XR)
  • saxagliptin (Onglyza)
  • saxagliptin-metformin (Kombiglyze XR)
  • sitagliptin (Januvia)
  • sitagliptin-metformin (Janumet and Janumet XR)
  • sitagliptin and simvastatin (Juvisync)

Glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists)

GLP-1 receptor agonists are similar to incretin and may be prescribed in addition to a diet and exercise plan to help promote better glycemic control.

They increase how much insulin your body uses and the growth of pancreatic beta cells. They decrease your appetite and how much glucagon your body uses. They also slow stomach emptying, which may maximize nutrient absorption from the foods you eat while potentially helping you maintain or lose weight.

These are all important actions for people with diabetes.

For some people, atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease may predominate over their diabetes. In these cases, the American Diabetes Association (ADA) recommends certain GLP-1 receptor agonists as part of an antihyperglycemic treatment regimen.

These drugs include:

  • dulaglutide (Trulicity)
  • exenatide (Byetta)
  • exenatide extended-release (Bydureon BCise)
  • liraglutide (Saxenda, Victoza)
  • lixisenatide (Adylyxin)
  • semaglutide (Ozempic)
  • tirzepatide (Mounjaro)

Meglitinides

These medications help your body release insulin. However, they aren’t for everyone. In some cases, they may lower your blood sugar too much, especially if you have advanced kidney disease.

These drugs include:

  • nateglinide (Starlix)
  • repaglinide (Prandin)

Sodium-glucose transporter (SGLT) 2 inhibitors

Sodium-glucose transporter (SGLT) 2 inhibitors work by preventing the kidneys from holding on to glucose. Instead, your body gets rid of the glucose through your urine.

Again, in cases where atherosclerotic cardiovascular disease, heart failure, or chronic kidney disease predominate, the ADA recommends SGLT2 inhibitors as a possible treatment option. Examples include:

  • canagliflozin (Invokana)
  • canagliflozin-metformin (Invokamet, Invokamet XR)
  • dapagliflozin (Farxiga)
  • dapagliflozin-metformin (Xigduo XR)
  • dapagliflozin-saxagliptin (Qtern)
  • empagliflozin (Jardiance)
  • empagliflozin-linagliptin (Glyxambi)
  • empaglifozin-linagliptin-metmorfin (Trijardy XR)
  • empagliflozin-metformin (Synjardy, Synjardy XR)
  • ertugliflozin (Steglatro)

Sulfonylureas

These are among the oldest diabetes drugs still used today. They work by stimulating the pancreas with the help of beta cells. This causes your body to make more insulin.

These drugs include:

  • glimepiride (Amaryl)
  • glimepiride-pioglitazone (Duetact)
  • gliclazide
  • glipizide
  • glipizide ER (Glipizide XL, Glucotrol XL)
  • glipizide-metformin
  • glyburide (Glynase)
  • glyburide-metformin

Thiazolidinediones

Thiazolidinediones work by decreasing glucose in your liver. They also help your fat cells use insulin better by targeting insulin resistance.

These drugs come with an increased risk of heart disease. If your doctor gives you one of these drugs, they’ll watch your heart function during treatment.

Options include:

  • rosiglitazone
  • pioglitazone-alogliptin (Oseni)
  • pioglitazone-glimepiride (Duetact)
  • pioglitazone-metformin (Actoplus Met, Actoplus Met XR)

People with type 1 and type 2 diabetes often need to take other medications to treat conditions that are common with diabetes.

These drugs can include:

Many medications are available to treat type 1 and type 2 diabetes. They each work in different ways to help you control your blood sugar.

Ask a doctor which diabetes drug may be the best fit for you. They will make recommendations based on the type of diabetes you have, your health, and other factors. It’s also important to know that new medications for diabetes are constantly being investigated for approval.

Read this article in Spanish.

Tue, 11 Oct 2022 12:00:00 -0500 en text/html https://www.healthline.com/health/diabetes/medications-list
Killexams : Public Safety Academy (PSA) Killexams : Public Safety Academy (PSA)

Interested in a Career in Public Safety?

The Department of Criminal Justice's Public Safety Academy provides Georgia Peace Officer Standards and Training Council (P.O.S.T.) basic law enforcement certification to students who declare a major in criminal justice and meet all P.O.S.T. mandates and requirements for acceptance into the P.O.S.T. program from the baccalaureate program on UNG's Dahlonega campus.

  • Please fully read the Requirements and Application Process page.
  • We do not offer a traditional 12-week academy. This program takes UNG students three to four years to complete.
  • This program is only offered on the Dahlonega Campus.

How Does This Program Prepare Me to Go into Public Safety?

Certification through the Public Safety Academy at UNG ensures you will be "job-ready" at graduation. Our academy also provides extensive training including in-service that exceeds far beyond the basic certification requirements. The following certifications are included:

Basic Certification

  • Basic law enforcement mandate certification (including First Aid/CPR, emergency vehicle operations, and firearms, pepper spray) at the time of graduation with a Bachelor's of Science in Criminal Justice.

Additional Certifications Included in UNG's Academy

  • Taser certification
  • ASP baton certification
  • Patrol rifle familiarization
  • Standardized field sobriety
  • Radar/Lidar

...it gives you more training than just the regular police academy. It gives you more time in the classroom, more time with the firearms, more time with instructors, basically just overall more training that gets you prepared."

Alexis Sutton, '19

Student, career goal to become an FBI homicide detective

What Can I Do with a Career in Public Safety?

"The Peace Officer Standards and Training Council (P.O.S.T.) congratulates the continued success of the University of North Georgia’s Public Safety Academy. This unique program is the first of its kind in our state. POST is honored to have assisted in its creation through the vision of Dr. Butch Newkirk. It is our shared belief that this program of study has and will continue to equip some of our most talented law enforcement professionals. Through the pursuit of a college degree and a POST law enforcement certification, graduates of this program are highly sought after in the law enforcement profession. The foundation to create through the North Georgia College Program will no doubt prepare its graduates for a successful career in law enforcement, many of whom will become the future leaders of our profession."

Mike Ayers, Executive Director
Georgia Peace Officer Standards and Training Council

 

Artwork of Challenge Coin

University of North Georgia, Public Safety Academy, Challenge Coin

Be Without Fear in the Face of Your Enemies

Find out more about the Public Safety Academy at UNG!

Public Safety Academy Students in Action

Establishing Connection...

Wed, 23 May 2018 02:28:00 -0500 en text/html https://ung.edu/criminal-justice/public-safety-academy/index.php
Killexams : Certification Market Share 2022 to 2028: Gross Margin, Size, Emerging Technology by Regional Forecast

The MarketWatch News Department was not involved in the creation of this content.

certification market current trends and future insights Report by 2028

Sep 28, 2022 (Heraldkeepers) -- A novel report on global Certification market has been recently added to Xcellent Insights' database that offers a comprehensive analysis of the global Certification industry. The report provides precise information about current and upcoming market trends, market drivers, restraints, challenges and risk factors that can impact the market growth. It also sheds light on marketing strategies, landscape, technologies, production costs and import/export utilization.

In addition, the report offers a detailed overview of the global Certification market pre and post COVID-19 pandemic and the different strategies adopted by market players to recover the loses during COVID-19 pandemic and retain their market position.

Get PDF demo Report + All Related Table and Graphs @: https://xcellentinsights.com/enquiry/sample/192222

The Certification market is expected register a robust revenue CAGR of 5.50% during the forecast period and reach USD 67470 billion by 2028. The report emphasizes on various factors and their impacts on the market growth. The report also offers detailed information about the key players and emerging players in the market including information such as market standing, expansion plans, revenue generation, product base and other activities.

Certification Market Top Companies Include:

?SGS
?TUV SUD
?UL
?Applus
?Bureau Veritas
?Intertek
?TUV Rheinland
?TUV NORD
?DNV
?Eurofins Scientific
?China Certification & Inspection
?ALS Global
?SIRIM QAS
?Dekra
?Lloyd’s Register

Key Questions Addressed in the Report:

  • What are the primary factors expected to drive global market growth during the forecast period?
  • Which factors are expected to hamper overall market growth over the forecast period?
  • Which current trends are expected to offer promising growth prospects in the coming years?
  • Which key players are operating in the global Certification market?
  • What are some vital challenges faced by key players in the global Certification market?
  • How is the competitive landscape of global Certification market at present?
  • Which regional market is expected to account for largest revenue share between 2017 and 2028?


Certification Market Segmentation:

Certification Market by Type:

?Aerospace & automotive Certification
?Retail & Consumer Good Certification
?Railway Certification
?Mgmt Systems Certification
?Environment Certification
?Health and Safety Industry Certification
?Medical Device Certification
?Product Certification
?Food Safety Certification

Certification Market by Application:

?Large Enterprises
?SMEs

Certification Market Segment by Region:

  • North America
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
  • Middle East & Africa

Would you like to ask a question? Ask Our Expert @: https://xcellentinsights.com/enquiry/buying/192222


Reasons to Purchase This Report:

  • Estimates 2017-2027 Certification market dynamics, development and trends
  • Detailed overview of the market including market size, share, growth opportunities, and challenges in the years to come
  • Market segmentation analysis with qualitative and quantitative research incorporating impact of economic and political aspects
  • Competitive landscape focusing on detailed information about every market player along with new projects and strategies adopted by them.
  • Comprehensive analysis of company profiles covering product offerings, exact developments, SWOT analysis, licence agreement and other strategies adopted by key players in the Certification market.

Direct Purchase Report @ https://xcellentinsights.com/checkout/192222

Report Customization:

Thank you for memorizing this report, kindly let us know if you wish to avail a customized copy of the report. Our team will provide you with the custom report as per your requirement.

Do you have any questions about how the COVID 19 has affected the Certification market? https://xcellentinsights.com/reports/certification-market-192222


Certification Market Table of Content (ToC):

1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Certification
1.2 Key Market Segments
1.2.1 Certification Segment by Type
1.2.2 Certification Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Certification Market Overview
2.1 Global Certification Market Size (M USD) Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Certification Market Competitive Landscape
3.1 Global Certification Revenue Market Share by Manufacturers (2017-2022)
3.2 Certification Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturers Certification Sales Sites, Area Served, Service Type
3.4 Certification Market Competitive Situation and Trends
3.4.1 Certification Market Concentration Rate
3.4.2 Global 5 and 10 Largest Certification Players Market Share by Revenue
3.4.3 Mergers & Acquisitions, Expansion
4 Certification Value Chain Analysis
4.1 Certification Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 The Development and Dynamics of Certification Market
5.1 Key Development Trends5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 Mergers & Acquisitions
5.5.2 Expansions
5.5.3 Collaboration/Supply Contracts
5.6 Industry Policies
6 Certification Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Certification Market Size Market Share by Type (2017-2022)
6.3 Global Certification Sales Growth Rate by Type (2017-2022)
7 Certification Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Certification Market Size (M USD) by Application (2017-2022)
7.3 Global Certification Sales Growth Rate by Application (2017-2022)
8 Certification Market Segmentation by Region
8.1 Global Certification Market Size by Region
8.1.1 Global Certification Market Size by Region
8.1.2 Global Certification Market Share by Region
8.2 North America
8.2.1 North America Certification Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Certification Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Certification Market Size by Region8.4.2 China8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Certification Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Certification Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profiled
9.1 SGS
9.1.1 SGS Certification Basic Information
9.1.2 SGS Certification Product Overview
9.1.3 SGS Certification Product Market Performance
9.1.4 SGS Business Overview
9.1.5 SGS Certification SWOT Analysis
9.1.6 SGS exact Developments
9.2 TUV SUD
9.2.1 TUV SUD Certification Basic Information
9.2.2 TUV SUD Certification Product Overview
9.2.3 TUV SUD Certification Product Market Performance
9.2.4 TUV SUD Business Overview
9.2.5 TUV SUD Certification SWOT Analysis
9.2.6 TUV SUD exact Developments
9.3 UL
9.3.1 UL Certification Basic Information
9.3.2 UL Certification Product Overview
9.3.3 UL Certification Product Market Performance
9.3.4 UL Business Overview
9.3.5 UL Certification SWOT Analysis
9.3.6 UL exact Developments
9.4 Applus
9.4.1 Applus Certification Basic Information
9.4.2 Applus Certification Product Overview9.4.3 Applus Certification Product Market Performance
9.4.4 Applus Business Overview
9.4.5 Applus Certification SWOT Analysis
9.4.6 Applus exact Developments
9.5 Bureau Veritas
9.5.1 Bureau Veritas Certification Basic Information
9.5.2 Bureau Veritas Certification Product Overview
9.5.3 Bureau Veritas Certification Product Market Performance
9.5.4 Bureau Veritas Business Overview
9.5.5 Bureau Veritas Certification SWOT Analysis
9.5.6 Bureau Veritas exact Developments
9.6 Intertek
9.6.1 Intertek Certification Basic Information
9.6.2 Intertek Certification Product Overview
9.6.3 Intertek Certification Product Market Performance
9.6.4 Intertek Business Overview
9.6.5 Intertek exact Developments
9.7 TUV Rheinland
9.7.1 TUV Rheinland Certification Basic Information
9.7.2 TUV Rheinland Certification Product Overview
9.7.3 TUV Rheinland Certification Product Market Performance
9.7.4 TUV Rheinland Business Overview
9.7.5 TUV Rheinland exact Developments
9.8 TUV NORD
9.8.1 TUV NORD Certification Basic Information
9.8.2 TUV NORD Certification Product Overview
9.8.3 TUV NORD Certification Product Market Performance
9.8.4 TUV NORD Business Overview
9.8.5 TUV NORD exact Developments
9.9 DNV
9.9.1 DNV Certification Basic Information
9.9.2 DNV Certification Product Overview
9.9.3 DNV Certification Product Market Performance
9.9.4 DNV Business Overview
9.9.5 DNV exact Developments
9.10 Eurofins Scientific
9.10.1 Eurofins Scientific Certification Basic Information
9.10.2 Eurofins Scientific Certification Product Overview
9.10.3 Eurofins Scientific Certification Product Market Performance
9.10.4 Eurofins Scientific Business Overview
9.10.5 Eurofins Scientific exact Developments
9.11 China Certification & Inspection9.11.1 China Certification & Inspection Certification Basic Information
9.11.2 China Certification & Inspection Certification Product Overview
9.11.3 China Certification & Inspection Certification Product Market Performance
9.11.4 China Certification & Inspection Business Overview
9.11.5 China Certification & Inspection exact Developments
9.12 ALS Global
9.12.1 ALS Global Certification Basic Information
9.12.2 ALS Global Certification Product Overview
9.12.3 ALS Global Certification Product Market Performance
9.12.4 ALS Global Business Overview
9.12.5 ALS Global exact Developments
9.13 SIRIM QAS
9.13.1 SIRIM QAS Certification Basic Information
9.13.2 SIRIM QAS Certification Product Overview
9.13.3 SIRIM QAS Certification Product Market Performance
9.13.4 SIRIM QAS Business Overview
9.13.5 SIRIM QAS exact Developments
9.14 Dekra
9.14.1 Dekra Certification Basic Information
9.14.2 Dekra Certification Product Overview
9.14.3 Dekra Certification Product Market Performance
9.14.4 Dekra Business Overview
9.14.5 Dekra exact Developments
9.15 Lloyd’s Register
9.15.1 Lloyd’s Register Certification Basic Information
9.15.2 Lloyd’s Register Certification Product Overview
9.15.3 Lloyd’s Register Certification Product Market Performance
9.15.4 Lloyd’s Register Business Overview
9.15.5 Lloyd’s Register exact Developments
10 Certification Regional Market Forecast
10.1 Global Certification Market Size Forecast
10.2 Global Certification Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Certification Market Size Forecast by Country
10.2.3 Asia Pacific Certification Market Size Forecast by Region
10.2.4 South America Certification Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Certification by Country
11 Market Segmentation & Size Forecast (2023-2028)
11.1 Global Certification Market Forecast by Type (2023-2028)11.2 Global Certification Market Forecast by Application (2023-2028)
12 Conclusion and Key Findings

About Us:

Xcellent Insights is a one-stop solution for market research and consulting. Our portfolio of services includes syndicate and bespoke research reports driven by market intelligence studies that allow you to add value to your trading decisions. You can count on us for end-to-end market research, market intelligence and service research and services. Having a diverse portfolio across multiple industries, Market Reports excels in providing in-depth analysis and covering the latest market and industry trends. At Great Ideas, we strive to offer our clients the best of our services through market research studies that greatly benefit them.

Contact Us:

Name: Susan W

Phone: Us: +1 4086277717

UK: +44 2086386439

Email: sales@xcellentinsights.com

Browse More Industry Report as Following Below:

The post Certification Market Share 2022 to 2028: Gross Margin, Size, Emerging Technology by Regional Forecast appeared first on Herald Keeper.

COMTEX_415518215/2582/2022-09-28T22:32:02

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Wed, 28 Sep 2022 10:32:00 -0500 en-US text/html https://www.marketwatch.com/press-release/certification-market-share-2022-to-2028-gross-margin-size-emerging-technology-by-regional-forecast-2022-09-28 Killexams : Ted Budd’s refusal to answer a basic question shows he really is an election denier No result found, try new keyword!“This is something that, until 2020, I think most Americans took for granted as a basic tenet of democracy.” The Charlotte Observer and Raleigh News & Observer editorial boards combined in ... Wed, 21 Sep 2022 10:37:00 -0500 text/html https://www.charlotteobserver.com/opinion/article266036651.html Killexams : ‘Staggering’ fraud: NY AG Letitia James sues Donald Trump, kids and company

New York Attorney General Letitia James on Wednesday filed a $250 million lawsuit against former President Donald Trump, his kids Eric, Ivanka and Donald Trump Jr., and the Trump Organization — alleging “staggering” fraud in the family real estate business.

The 220-page civil suit filed in Manhattan Supreme Court accuses the former president and his Trump Organization of fraudulently inflating the value of his prized assets – including his homes and golf courses – to allegedly obtain favorable loans and tax benefits.

It seeks to tear away Trump’s ability to run businesses in the Empire State and to prohibit him and his company from buying up commercial real estate for several years.

“Donald Trump falsely inflated his net worth by billions of dollars to unjustly enrich himself, and cheat the system, thereby cheating all of us,” James, a Democrat, said at a news conference.

“Claiming you have money that you do not have does not amount to the art of the deal, it’s the art of the steal,” she said, referring to Trump’s 1987 book.

James said her office, following a three-year investigation, uncovered possible criminal violations, including of falsifying business records, insurance fraud, issuing false financial statement, conspiracy and bank fraud.

While she can’t bring criminal charges against Trump because her probe was a civil one, James said her office is referring the case to the Internal Revenue Service and to federal prosecutors in the Southern District of New York.

NY AG Letitia James filed suit Wednesday against Donald Trump, his three kids Ericm Don. Jr. and Ivanka, as well as the Trump Organization alleging fraudulent business practices.
NY AG Letitia James filed suit Wednesday against Donald Trump, his three oldest kids Eric, Don Jr. and Ivanka, as well as the Trump Organization, alleging fraudulent business practices.
William Farrington

The suit, which also names ex-Trump Organization CFO Allen Weisselberg, alleges the defendants “engaged in numerous acts of fraud and misrepresentation in the preparation of Mr. Trump’s annual statements of financial condition … covering at least the years 2011 through 2021.”

Specifically, James alleges that Trump and the co-defendants used a slew of tricks — including making at least 200 false or misleading statements inflating assets — to carry out a conspiracy that netted them at least $250 million.

James said these misrepresentations — which falsely showed Trump made billions more than he did in reality — were made on “Statements of Financial Condition” that were given to financial institutions such as Cushman & Wakefield, Deutsche Bank and Mazars Group for loan applications and for insurance purposes.

As a result, the defendants received favorable loan and insurance terms, which included higher limits and lower premiums, the suit claims.

“Each statement was personally certified as accurate by Mr. Trump or by one of his trustees,” James alleged.

Trump would lie about the amount of cash he had on hand and would overvalue his real estate properties by using different methods to value the same properties from one year to the next, James claimed.

He would inflate property prices by factoring in a potential boost in value from the Trump Brand, and also ignored legal restrictions on development rights, the AG claimed.

Trump would lie about the amount of cash he had on hand, he would overvalue his real estate properties, and ignored legal restrictions on development rights, James claimed.

For instance, Trump valued his 40 Wall Street property at as much as $530 million in 2013 when it was actually appraised at $220 million in 2012, the court papers claim.

He also exaggerated the square footage of his triplex in Trump Tower, claiming it was 30,000 square feet when it was actually just under 11,000 square feet, the suit alleges. This exaggeration meant that the property was valued at $327 million — a price that no apartment in New York has ever sold for, James said.

The AG claims Trump, three of his kids and company employees made fraudulent representations about Trump's financial condition.
The AG claims Trump, three of his kids and company employees made fraudulent representations about Trump’s financial condition.
AFP via Getty Images

Trump claimed that 12 rent-controlled apartments at Trump Park Avenue were worth $50 million total when they were valued by a third-party appraiser at $750,000 total, the suit states.

Meanwhile, James also alleged the Trump Organization was able to lower its federal tax obligations through the purported scheme.

For instance, the suit alleges that Eric Trump led the company’s efforts to develop the Seven Springs estate in Westchester County from 2011 – and worked with an outside tax council to get a federal tax deduction by completing a conservation easement donation.

Eric invoked the Fifth Amendment when asked about the easement donation related to Seven Springs, which “ultimately, and fraudulently, reduced Mr. Trump’s tax liability by more than $3.5 million.”

“The examples I laid out just barely scratch the surface of the misconduct,” James said.

In addition to seeking to ban Trump and the company from striking any real estate deals and getting loans in New York for five years, James also wants to permanently bar the ex-president, Don Jr., Ivanka and Eric from serving as directors in any local company.

The AG also wants the defendants to cough up any financial profits from the alleged fraudulent behavior totaling at least $250 million.

She is seeking to bar Weisselberg and Trump Organization controller Jeffrey McConney from having financial control over any company in New York going forward. And James wants an independent monitor to be installed to oversee compliance for the next five years, as well as for the Trump Organization to submit audited annual financial statements of Trump’s net worth that will also be sent to any company that previously received his statements of financial condition.

All of these restrictions that James seeks to impose must first be approved by a judge.

In a statement, Trump lawyer Alina Habba told The Post that the lawsuit “is neither focused on the facts nor the law — rather, it is solely focused on advancing the Attorney General’s political agenda.”

“It is abundantly clear that the Attorney General’s Office has exceeded its statutory authority by prying into transactions where absolutely no wrongdoing has taken place,” she said. “We are confident that our judicial system will not stand for this unchecked abuse of authority, and we look forward to defending our client against each and every one of the Attorney General’s meritless claims.”

Trump, meanwhile, accused James of a politically-motivated “witch hunt” in a statement on Truth Social platform.

His former attorney general, Bill Barr, also dismissed the suit as a “political hit job.”

“I think it will make people sympathetic for Trump that this is another example of people piling on because of ‘Trump derangement syndrome,’ you know, the strong desire to punish him,” he told Fox News.

He said it didn’t appear James had the evidence to make a criminal case, “so she’s setting a lower bar and bringing this civil case.”

“I don’t think it’s going to go any further,” Barr said.

James opened an investigation into the company in 2019 after Trump’s one-time personal lawyer Michael Cohen told Congress that Trump exaggerated company assets for tax, insurance and loan purposes.

The AG then filed suit in 2020, claiming the Trump Organization and Eric Trump were stonewalling her probe.

Trump and the other two of his three eldest kids, Ivanka and Donald Trump Jr., have since been added to the case, in which the office sought to enforce subpoenas for records and depositions from family members and company employees. All three of his kids have been execs in the company.

Trump, Ivanka and Don Jr. have fought appearing for depositions but ultimately lost that court battle, and Trump testified last month at the AG’s deposition, where he refused to answer questions, citing his Fifth Amendment rights.

Trump Tower
Ex-CFO Allen Weisselberg, who pleaded guilty to fraud last month in a criminal case, was also named in the suit.
Getty Images

The lawsuit on Wednesday comes after the AG rejected at least one offer by Trump’s camp to settle the case.

“We rejected settlement offers that they submitted and our doors are always open,” James told reporters.

A spokesman for the US Attorney of the Southern District of New York said Wednesday they were aware of James’ referral but declined to comment further.

Trump is also facing more legal woes following the Aug. 8 raid on the Mar-a-Lago resort in Florida as the FBI probes whether Trump unlawfully stashed classified documents there. He’s maintained that the documents were declassified before he brought them there.

James' office has been investigating the Trump Organization for over three years.
James’ office has been investigating the Trump Organization for over three years.
William Farrington

Trump lawyers were in Brooklyn federal court Tuesday as Judge Raymond Dearie, the court-appointed special master, works to determine which of the 11,000 seized documents could fall under attorney-client or executive privilege.

The Trump Organization is also set to face trial next month on charges of tax fraud where Weisselberg is slated to testify against the company as part of a plea deal he struck last month with the Manhattan District Attorney’s Office.

In the wake of James’ suit, Manhattan DA Alvin Bragg said in a statement: “Our criminal investigation concerning former President Donald J. Trump, the Trump Organization, and its leadership is active and ongoing.”

The company is accused of helping top execs get around income taxes by downplaying their compensation to the government for 15 years. Trump is not personally charged in the case.

If convicted, the company could face financial penalties and be forced to reform business practices.

Additional reporting by Elizabeth Rosner and Ben Feuerherd

Wed, 21 Sep 2022 03:47:00 -0500 en-US text/html https://nypost.com/2022/09/21/ny-ag-letitia-james-sues-donald-trump-kids-and-company/
PEGACSSA74V1 exam dump and training guide direct download
Training Exams List